DK0591275T3 - Anvendelse af 2-(2-nitro-4-trifluormethylbenzoyl)-1,3-cyklohexandion til behandling af tyrosinæmi samt farmaceutiske sammen - Google Patents

Anvendelse af 2-(2-nitro-4-trifluormethylbenzoyl)-1,3-cyklohexandion til behandling af tyrosinæmi samt farmaceutiske sammen

Info

Publication number
DK0591275T3
DK0591275T3 DK92912215T DK92912215T DK0591275T3 DK 0591275 T3 DK0591275 T3 DK 0591275T3 DK 92912215 T DK92912215 T DK 92912215T DK 92912215 T DK92912215 T DK 92912215T DK 0591275 T3 DK0591275 T3 DK 0591275T3
Authority
DK
Denmark
Prior art keywords
cyclohexanedione
trifluoromethylbenzoyl
anemia
tyrosine
nitro
Prior art date
Application number
DK92912215T
Other languages
Danish (da)
English (en)
Inventor
Martin Keith Ellis
Sven Torvald Lindstedt
Edward Alan Lock
Maj Elisabeth Holme Markstedt
Linda Carol Mutter
Michael Paul Prisbylla
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919113622A external-priority patent/GB9113622D0/en
Priority claimed from GB929206412A external-priority patent/GB9206412D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of DK0591275T3 publication Critical patent/DK0591275T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
DK92912215T 1991-06-24 1992-06-18 Anvendelse af 2-(2-nitro-4-trifluormethylbenzoyl)-1,3-cyklohexandion til behandling af tyrosinæmi samt farmaceutiske sammen DK0591275T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919113622A GB9113622D0 (en) 1991-06-24 1991-06-24 Medicinal agents
GB929206412A GB9206412D0 (en) 1992-03-24 1992-03-24 Pharmaceutical compositions
PCT/GB1992/001094 WO1993000080A1 (fr) 1991-06-24 1992-06-18 Utilisation de 2-(2-nitro-4-trifluoromethylbenzoyle)-1,3-cyclohexanedione pour le traitement de la tirosinemie et compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
DK0591275T3 true DK0591275T3 (da) 1999-10-11

Family

ID=26299120

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92912215T DK0591275T3 (da) 1991-06-24 1992-06-18 Anvendelse af 2-(2-nitro-4-trifluormethylbenzoyl)-1,3-cyklohexandion til behandling af tyrosinæmi samt farmaceutiske sammen

Country Status (16)

Country Link
US (1) US5550165A (fr)
EP (1) EP0591275B1 (fr)
JP (1) JP3130935B2 (fr)
AT (1) ATE178207T1 (fr)
AU (1) AU672361B2 (fr)
CA (1) CA2072047C (fr)
DE (2) DE69228813T2 (fr)
DK (1) DK0591275T3 (fr)
ES (1) ES2129448T3 (fr)
GR (1) GR3029841T3 (fr)
IE (1) IE922024A1 (fr)
LU (1) LU91180I2 (fr)
NL (1) NL300198I2 (fr)
NO (3) NO304923B1 (fr)
PT (1) PT100619B (fr)
WO (1) WO1993000080A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4305696A1 (de) * 1993-02-25 1994-09-01 Hoechst Ag Nachweisverfahren zur Identifizierung von Inhibitoren
ATE276754T1 (de) * 1998-07-21 2004-10-15 Cytovia Inc Neue fluoreszensfarbstoffe und ihre anwendung in fluoreszensnachweisverfahren ganzer zellen für kaspasen, peptidasen, proteasen und andere enzyme sowie deren verwendung
GB0504103D0 (en) * 2005-02-28 2005-04-06 Syngenta Ltd Novel method
NZ574153A (en) * 2006-08-18 2011-12-22 Syngenta Ltd Use of hppd inhibitors in the treatment of depression and/or withdrawal symptoms associated with addictive drugs
PH12012501552A1 (en) * 2010-01-29 2017-04-26 Toray Industries Therapeutic or prophylactic agent for biliary diseases
RS54632B1 (sr) 2011-06-23 2016-08-31 Swedish Orphan Biovitrum International Ab Tečna farmaceutska kompozicija koja sadrži nitizinon
WO2013181292A1 (fr) * 2012-05-29 2013-12-05 Biotie Therapies, Inc. Formulations de nitisinone
CN102976948B (zh) * 2012-11-28 2014-07-09 郑州大明药物科技有限公司 尼替西农的制备方法
GB201400117D0 (en) 2014-01-03 2014-02-19 Cycle Pharmaceuticals Ltd Pharmaceutical composition
ITUB20160650A1 (it) * 2016-02-11 2017-08-11 Dipharma S A Formulazioni farmaceutiche solide stabili contenenti 2-(2-nitro-4-trifluorometilbenzoil)-1,3-cicloesandione
US9783485B1 (en) 2016-11-30 2017-10-10 Dipharma S.A. Crystalline inhibitor of 4-hydroxyphenylpyruvate dioxygenase, and a process of synthesis and crystallization thereof
EP3888684A1 (fr) * 2020-03-31 2021-10-06 Bayer Animal Health GmbH Composition ayant une acceptation volontaire améliorée
CN112460914A (zh) * 2020-11-01 2021-03-09 江苏珠合新能源科技有限公司 一种干冰机尾气冷量回收调节工艺装置
WO2024047657A1 (fr) * 2022-08-28 2024-03-07 Brawn Laboratories Ltd Procédé de préeparation de nitisinone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780127A (en) * 1982-03-25 1988-10-25 Stauffer Chemical Company Certain 2-(substituted benzoyl)-1,3-cyclohexanediones and their use as herbicides
IL77349A (en) * 1984-12-20 1990-07-12 Stauffer Chemical Co 2-(2'-nitrobenzoyl)-1,3-cyclohexanediones,their preparation and their use as herbicides
US4774360A (en) * 1987-06-29 1988-09-27 Stauffer Chemical Company Converting enol ester precursor of a benzoyl-1,3-cycloalkyldione to a benzoyl-1,3-cycloalkyldione
US4859234A (en) 1987-09-14 1989-08-22 Ici Americas Inc. Herbicidal compositions of acylated 1,3-dicarbonyl herbicides and phenoxyalkanoic acids, salts, amides and esters therof as antidotes

Also Published As

Publication number Publication date
NO304923B1 (no) 1999-03-08
NO934798D0 (no) 1993-12-23
NL300198I2 (nl) 2005-09-01
EP0591275A1 (fr) 1994-04-13
GR3029841T3 (en) 1999-07-30
CA2072047A1 (fr) 1992-12-25
AU1986092A (en) 1993-01-25
NO2017045I1 (no) 2017-08-23
PT100619B (pt) 1999-07-30
EP0591275B1 (fr) 1999-03-31
DE122005000032I1 (de) 2005-09-29
NL300198I1 (nl) 2005-08-01
DE69228813T2 (de) 1999-08-05
NO934798L (no) 1993-12-23
LU91180I2 (fr) 2005-09-06
ATE178207T1 (de) 1999-04-15
AU672361B2 (en) 1996-10-03
PT100619A (pt) 1994-01-31
DE122005000032I2 (de) 2006-06-08
NO2005018I1 (no) 2005-09-26
NO2005018I2 (no) 2008-02-11
DE69228813D1 (de) 1999-05-06
JPH06508628A (ja) 1994-09-29
JP3130935B2 (ja) 2001-01-31
HK1008662A1 (en) 1999-05-14
ES2129448T3 (es) 1999-06-16
IE922024A1 (en) 1992-12-30
WO1993000080A1 (fr) 1993-01-07
US5550165A (en) 1996-08-27
CA2072047C (fr) 2003-06-10

Similar Documents

Publication Publication Date Title
NO2017045I1 (no) Farmasøøytisk preparat inneholdende 2-(2-nitro-4-ifluormetylbenzoyl)-1,3-cykloheksandion eller et farmasøytisk godtagbart salt derav
NL300175I2 (nl) Methylsulfonylfenyl-2-(5H)-furanonen als remmers van COX-2.
DE69410092D1 (en) Phenyl heterocyclen als cyclooxygenase-2 inhibitoren
ATE203019T1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane
TNSN98017A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26723A1 (fr) Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97198A1 (fr) Derives de 6-phenylpyridyl-2- amine et compositions pharmaceutiques les contenant
MA27937A1 (fr) Dérivés d'indazole 3, 5-disubstitués, compositions pharmaceutiques, et méthodes de médiation ou d'inhibition de la prolifération cellulaire
DE60329316D1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
BR9713186A (pt) Inibidores de metaloprotease 1,3-diheterocìclicos
CA2224528A1 (fr) Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations
ATE212343T1 (de) 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren
DE69816047D1 (en) (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer
ES2062891T3 (es) Compuestos de 1,2,3,4-oxatriazol-5-imina 3-sustituidos, un proceso para la preparacion de los mismos y un preparado farmaceutico que contiene tales compuestos.
CA2291650A1 (fr) Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
DE59101267D1 (de) N-Alkyl-N-(meth)acryloyloxyalkylcarboxamide aromatischer Carbonsäuren und aromatischer Carbonsäureanhydride sowie Adhäsive enthaltend diese Verbindungen.
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
TR200101222T2 (tr) Matris metaloproteaz ile ilgili hastalıklar için tedavi edici amiller olarak sistin türevleri
ATE308984T1 (de) Arzneiformen zur behandlung von krankheiten, die auf aktivierung des ppar-gamma-rezeptors ansprechen
ES2168508T3 (es) Empleo de treonina para el tratamiento de fenil-cetonuria.
TH45444A (th) (เมทิลซัลโฟนิล) ฟีนิล-2-(5h)-ฟูราโนน ที่เป็นตัวขัดขวาง cox-2
GEP20033130B (en) Inhibitors of IMPDH Enzyme
GEP20022764B (en) HIV Protease Inhibitors, Pharmaceutical Compositions and Methods for Inhibiting HIV Protease
EP0191253A3 (fr) Compositions pharmaceutiques à base de 3-phényl-4-diéthylamino-éthyl-5-imino-1,2,4-oxadiazoline en tant qu'agents vaso-constricteur